Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

G-CSF stimulant

DRUG CLASS:

G-CSF stimulant

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	cytarabine + cladribine + Nugraf (filgrastim biosimilar) Sensitive: A2 - Guideline cytarabine + cladribine + Nugraf (filgrastim biosimilar) Sensitive : A2	cytarabine + cladribine + Nugraf (filgrastim biosimilar) Sensitive: A2 - Guideline cytarabine + cladribine + Nugraf (filgrastim biosimilar) Sensitive : A2
No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	cytarabine + idarubicin hydrochloride + cladribine + Nugraf (filgrastim biosimilar) Sensitive: A2 - Guideline cytarabine + idarubicin hydrochloride + cladribine + Nugraf (filgrastim biosimilar) Sensitive : A2	cytarabine + idarubicin hydrochloride + cladribine + Nugraf (filgrastim biosimilar) Sensitive: A2 - Guideline cytarabine + idarubicin hydrochloride + cladribine + Nugraf (filgrastim biosimilar) Sensitive : A2
No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	cytarabine + mitoxantrone + cladribine + Nugraf (filgrastim biosimilar) Sensitive: A2 - Guideline cytarabine + mitoxantrone + cladribine + Nugraf (filgrastim biosimilar) Sensitive : A2	cytarabine + mitoxantrone + cladribine + Nugraf (filgrastim biosimilar) Sensitive: A2 - Guideline cytarabine + mitoxantrone + cladribine + Nugraf (filgrastim biosimilar) Sensitive : A2
No biomarker	Breast Cancer	No biomarker	Breast Cancer	SV-BR-1-GM Sensitive: B - Late Trials SV-BR-1-GM Sensitive : B	SV-BR-1-GM Sensitive: B - Late Trials SV-BR-1-GM Sensitive : B
PD-L1 expression	Breast Cancer	PD-L1 expression	Breast Cancer	SV-BR-1-GM Sensitive: C3 – Early Trials SV-BR-1-GM Sensitive : C3	SV-BR-1-GM Sensitive: C3 – Early Trials SV-BR-1-GM Sensitive : C3
HER-2 negative	HER2 Negative Breast Cancer	HER-2 negative	HER2 Negative Breast Cancer	albumin-bound paclitaxel + cyclophosphamide + epirubicin + pegfilgrastim Sensitive: C3 – Early Trials albumin-bound paclitaxel + cyclophosphamide + epirubicin + pegfilgrastim Sensitive : C3	albumin-bound paclitaxel + cyclophosphamide + epirubicin + pegfilgrastim Sensitive: C3 – Early Trials albumin-bound paclitaxel + cyclophosphamide + epirubicin + pegfilgrastim Sensitive : C3